SCHEMBL5451191

SCHEMBL5451191

CCc1cccc2nc(N)n(CC)c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
HTT P42858 1/20 0.56
TLR8 Q9NR97 5/20 0.49
ELANE P08246 2/20 0.45
POLB P06746 1/20 0.45
PRMT5 O14744 1/20 0.42
TNF P01375 1/20 0.41
NOD2 Q9HC29 1/20 0.41
NOD1 Q9Y239 1/20 0.41
CXCR4 P61073 1/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
TSHR P16473 1/20 0.40
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
RPS6KA5 O75582 1/20 0.38
PRKACA P17612 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5454116 0.87 POLB (0.58) CYP1A2CYP2D6HTTTLR8ELANE
SCHEMBL5465854 0.84 TLR8 (0.66) CYP1A2CYP2D6HTTTLR8ELANE
SCHEMBL5463793 0.82 TLR8 (0.49) CYP1A2CYP2D6HTTTLR8ELANE
SCHEMBL5470484 0.81 PRMT5 (0.60) CYP1A2CYP2D6HTTTLR8ELANE
SCHEMBL5463706 0.80 PRMT5 (0.63) CYP1A2CYP2D6HTTTLR8POLB
SCHEMBL5453997 0.80 TLR8 (0.53) TLR8POLBCXCR4KDM4EALDH1A1
SCHEMBL5454046 0.78 KMT2A (0.51) HTTTLR8POLBNOD1KDM4E
SCHEMBL5454917 0.76 TLR8 (0.43) CYP1A2CYP2D6HTTTLR8POLB
SCHEMBL5480691 0.75 MTNR1A (0.55) HTTTLR8POLBALDH1A1LMNA
SCHEMBL5480685 0.75 TLR8 (0.48) CYP1A2CYP2D6HTTTLR8ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232673-A1 2-Imino-benzimidazoles CYP2C19, UGT2B7, UGT2B17 CYP1A2 9/4885CYP2D6 17/4885HTT 4363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.